Loading…
Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016
Background. Hepatitis C virus (HCV) infection incidence rates in the United States have increased since 2010 as a byproduct of the opioid crisis despite the introduction of direct-acting antiviral agents in 2013. HCV infection is associated with higher rates of liver-related and nonhepatic causes of...
Saved in:
Published in: | Canadian Journal of Gastroenterology and Hepatology 2022, Vol.2022, p.1-8 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c471t-c1c7ad6bea3345936337a1669b76a81d038376cec590d2e2924739fc7d97de003 |
container_end_page | 8 |
container_issue | |
container_start_page | 1 |
container_title | Canadian Journal of Gastroenterology and Hepatology |
container_volume | 2022 |
creator | Bressler, Sara S. Bruden, Dana Nolen, Leisha D. Bruce, Michael G. Towshend-Bulson, Lisa Spradling, Philip McMahon, Brian J. |
description | Background. Hepatitis C virus (HCV) infection incidence rates in the United States have increased since 2010 as a byproduct of the opioid crisis despite the introduction of direct-acting antiviral agents in 2013. HCV infection is associated with higher rates of liver-related and nonhepatic causes of death. Methods. This study compared demographic characteristics and age-adjusted death rates from 1995 to 2016 among Alaska Native (AN) adults infected with HCV (AK-HepC) to rates among the AN and non-AN adult populations living in Alaska. Liver-related disease (LRD) and other disease-specific age-adjusted death rates were compared between the populations. Results. The all-cause death rate among the AK-HepC cohort was 2.2- and 3.4-fold higher than AN and non-AN adults, respectively, and remained stable over time in all populations. The LRD death rate among the AK-HepC cohort was 18- and 11-fold higher than the non-AN and AN, respectively. The liver cancer rate among the AK-HepC cohort was 26-fold higher compared to the Alaska statewide population. The AK-HepC cohort had elevated rates of death associated with nonhepatic diseases with circulatory disease having the highest rate in all populations. Among liver cancer deaths in the AK-HepC cohort, 32% had HCV listed as a contributing cause of death on the death certificate. Conclusions. Death rates in the AK-HepC cohort remained stable since 1995 and higher compared to the general population. People with HCV infection had an elevated risk for all-cause, liver-related, and nonhepatic causes of death. Hepatitis C infection may be underrepresented as a cause of mortality in the United States. |
doi_str_mv | 10.1155/2022/2573545 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8847038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e7f7ed0da63d4fc3819c2a9bc3d6b73c</doaj_id><sourcerecordid>2630681280</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-c1c7ad6bea3345936337a1669b76a81d038376cec590d2e2924739fc7d97de003</originalsourceid><addsrcrecordid>eNp9kstuGyEUhlHVqonc7PoASF02brgMMGwqWVaaWEovi7ZbhIGxcccwBSZRdt13mTfMkxRfFCmbrkCcj__8_9EB4C1GHzBm7IIgQi4IE5Q17AU4JUTiKRFSvHy6t_IEnOW8QQhhwpik5DU4oQyLlvLmFPz9HFPRvS_3UG9jWMFZr_MvDb_o4m8dnNmxLxne-bKG8xg6n7bOwms31HLxGc7hT5_GDBehc6b4GCq1HXSq0P5PWTt45YJLuoff4jD2eg_5cOxzDrGU7PHPA0GYvwGvOt1nd3Y8J-DHp8vv8-vpzderxXx2MzWNwGVqsBHa8qXTlDY1EKdUaMy5XAquW2wRbangxhkmkSWOSNIIKjsjrBTWIUQnYHHQtVFv1JD8Vqd7FbVX-4eYVkqn4k3vlBOdcBZZzaltOkNbLA3RcmloNSCoqVofD1rDuKyjMS6UmvWZ6PNK8Gu1ireqbRuxczoB744CKf4eXS5qE8cUan5FOEW8xaTdWT4_UCbFnJPrnjpgpHaboHaboI6bUPH3B3ztg9V3_v_0P6MRshU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2630681280</pqid></control><display><type>article</type><title>Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Bressler, Sara S. ; Bruden, Dana ; Nolen, Leisha D. ; Bruce, Michael G. ; Towshend-Bulson, Lisa ; Spradling, Philip ; McMahon, Brian J.</creator><contributor>Granito, Alessandro ; Alessandro Granito</contributor><creatorcontrib>Bressler, Sara S. ; Bruden, Dana ; Nolen, Leisha D. ; Bruce, Michael G. ; Towshend-Bulson, Lisa ; Spradling, Philip ; McMahon, Brian J. ; Granito, Alessandro ; Alessandro Granito</creatorcontrib><description>Background. Hepatitis C virus (HCV) infection incidence rates in the United States have increased since 2010 as a byproduct of the opioid crisis despite the introduction of direct-acting antiviral agents in 2013. HCV infection is associated with higher rates of liver-related and nonhepatic causes of death. Methods. This study compared demographic characteristics and age-adjusted death rates from 1995 to 2016 among Alaska Native (AN) adults infected with HCV (AK-HepC) to rates among the AN and non-AN adult populations living in Alaska. Liver-related disease (LRD) and other disease-specific age-adjusted death rates were compared between the populations. Results. The all-cause death rate among the AK-HepC cohort was 2.2- and 3.4-fold higher than AN and non-AN adults, respectively, and remained stable over time in all populations. The LRD death rate among the AK-HepC cohort was 18- and 11-fold higher than the non-AN and AN, respectively. The liver cancer rate among the AK-HepC cohort was 26-fold higher compared to the Alaska statewide population. The AK-HepC cohort had elevated rates of death associated with nonhepatic diseases with circulatory disease having the highest rate in all populations. Among liver cancer deaths in the AK-HepC cohort, 32% had HCV listed as a contributing cause of death on the death certificate. Conclusions. Death rates in the AK-HepC cohort remained stable since 1995 and higher compared to the general population. People with HCV infection had an elevated risk for all-cause, liver-related, and nonhepatic causes of death. Hepatitis C infection may be underrepresented as a cause of mortality in the United States.</description><identifier>ISSN: 2291-2789</identifier><identifier>EISSN: 2291-2797</identifier><identifier>DOI: 10.1155/2022/2573545</identifier><identifier>PMID: 35178364</identifier><language>eng</language><publisher>Oakville: Hindawi</publisher><subject>Adults ; Age ; Alcohol ; Baby boomers ; Diabetes ; Hepatitis C ; Infections ; Liver cancer ; Liver diseases ; Mortality ; Population</subject><ispartof>Canadian Journal of Gastroenterology and Hepatology, 2022, Vol.2022, p.1-8</ispartof><rights>Copyright © 2022 Sara S. Bressler et al.</rights><rights>Copyright © 2022 Sara S. Bressler et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Sara S. Bressler et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c471t-c1c7ad6bea3345936337a1669b76a81d038376cec590d2e2924739fc7d97de003</cites><orcidid>0000-0002-6439-9714</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2630681280/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2630681280?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,25753,27923,27924,27925,37012,44590,53791,53793,75126</link.rule.ids></links><search><contributor>Granito, Alessandro</contributor><contributor>Alessandro Granito</contributor><creatorcontrib>Bressler, Sara S.</creatorcontrib><creatorcontrib>Bruden, Dana</creatorcontrib><creatorcontrib>Nolen, Leisha D.</creatorcontrib><creatorcontrib>Bruce, Michael G.</creatorcontrib><creatorcontrib>Towshend-Bulson, Lisa</creatorcontrib><creatorcontrib>Spradling, Philip</creatorcontrib><creatorcontrib>McMahon, Brian J.</creatorcontrib><title>Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016</title><title>Canadian Journal of Gastroenterology and Hepatology</title><description>Background. Hepatitis C virus (HCV) infection incidence rates in the United States have increased since 2010 as a byproduct of the opioid crisis despite the introduction of direct-acting antiviral agents in 2013. HCV infection is associated with higher rates of liver-related and nonhepatic causes of death. Methods. This study compared demographic characteristics and age-adjusted death rates from 1995 to 2016 among Alaska Native (AN) adults infected with HCV (AK-HepC) to rates among the AN and non-AN adult populations living in Alaska. Liver-related disease (LRD) and other disease-specific age-adjusted death rates were compared between the populations. Results. The all-cause death rate among the AK-HepC cohort was 2.2- and 3.4-fold higher than AN and non-AN adults, respectively, and remained stable over time in all populations. The LRD death rate among the AK-HepC cohort was 18- and 11-fold higher than the non-AN and AN, respectively. The liver cancer rate among the AK-HepC cohort was 26-fold higher compared to the Alaska statewide population. The AK-HepC cohort had elevated rates of death associated with nonhepatic diseases with circulatory disease having the highest rate in all populations. Among liver cancer deaths in the AK-HepC cohort, 32% had HCV listed as a contributing cause of death on the death certificate. Conclusions. Death rates in the AK-HepC cohort remained stable since 1995 and higher compared to the general population. People with HCV infection had an elevated risk for all-cause, liver-related, and nonhepatic causes of death. Hepatitis C infection may be underrepresented as a cause of mortality in the United States.</description><subject>Adults</subject><subject>Age</subject><subject>Alcohol</subject><subject>Baby boomers</subject><subject>Diabetes</subject><subject>Hepatitis C</subject><subject>Infections</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Mortality</subject><subject>Population</subject><issn>2291-2789</issn><issn>2291-2797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstuGyEUhlHVqonc7PoASF02brgMMGwqWVaaWEovi7ZbhIGxcccwBSZRdt13mTfMkxRfFCmbrkCcj__8_9EB4C1GHzBm7IIgQi4IE5Q17AU4JUTiKRFSvHy6t_IEnOW8QQhhwpik5DU4oQyLlvLmFPz9HFPRvS_3UG9jWMFZr_MvDb_o4m8dnNmxLxne-bKG8xg6n7bOwms31HLxGc7hT5_GDBehc6b4GCq1HXSq0P5PWTt45YJLuoff4jD2eg_5cOxzDrGU7PHPA0GYvwGvOt1nd3Y8J-DHp8vv8-vpzderxXx2MzWNwGVqsBHa8qXTlDY1EKdUaMy5XAquW2wRbangxhkmkSWOSNIIKjsjrBTWIUQnYHHQtVFv1JD8Vqd7FbVX-4eYVkqn4k3vlBOdcBZZzaltOkNbLA3RcmloNSCoqVofD1rDuKyjMS6UmvWZ6PNK8Gu1ireqbRuxczoB744CKf4eXS5qE8cUan5FOEW8xaTdWT4_UCbFnJPrnjpgpHaboHaboI6bUPH3B3ztg9V3_v_0P6MRshU</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Bressler, Sara S.</creator><creator>Bruden, Dana</creator><creator>Nolen, Leisha D.</creator><creator>Bruce, Michael G.</creator><creator>Towshend-Bulson, Lisa</creator><creator>Spradling, Philip</creator><creator>McMahon, Brian J.</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6439-9714</orcidid></search><sort><creationdate>2022</creationdate><title>Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016</title><author>Bressler, Sara S. ; Bruden, Dana ; Nolen, Leisha D. ; Bruce, Michael G. ; Towshend-Bulson, Lisa ; Spradling, Philip ; McMahon, Brian J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-c1c7ad6bea3345936337a1669b76a81d038376cec590d2e2924739fc7d97de003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adults</topic><topic>Age</topic><topic>Alcohol</topic><topic>Baby boomers</topic><topic>Diabetes</topic><topic>Hepatitis C</topic><topic>Infections</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Mortality</topic><topic>Population</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bressler, Sara S.</creatorcontrib><creatorcontrib>Bruden, Dana</creatorcontrib><creatorcontrib>Nolen, Leisha D.</creatorcontrib><creatorcontrib>Bruce, Michael G.</creatorcontrib><creatorcontrib>Towshend-Bulson, Lisa</creatorcontrib><creatorcontrib>Spradling, Philip</creatorcontrib><creatorcontrib>McMahon, Brian J.</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Canadian Journal of Gastroenterology and Hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bressler, Sara S.</au><au>Bruden, Dana</au><au>Nolen, Leisha D.</au><au>Bruce, Michael G.</au><au>Towshend-Bulson, Lisa</au><au>Spradling, Philip</au><au>McMahon, Brian J.</au><au>Granito, Alessandro</au><au>Alessandro Granito</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016</atitle><jtitle>Canadian Journal of Gastroenterology and Hepatology</jtitle><date>2022</date><risdate>2022</risdate><volume>2022</volume><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>2291-2789</issn><eissn>2291-2797</eissn><abstract>Background. Hepatitis C virus (HCV) infection incidence rates in the United States have increased since 2010 as a byproduct of the opioid crisis despite the introduction of direct-acting antiviral agents in 2013. HCV infection is associated with higher rates of liver-related and nonhepatic causes of death. Methods. This study compared demographic characteristics and age-adjusted death rates from 1995 to 2016 among Alaska Native (AN) adults infected with HCV (AK-HepC) to rates among the AN and non-AN adult populations living in Alaska. Liver-related disease (LRD) and other disease-specific age-adjusted death rates were compared between the populations. Results. The all-cause death rate among the AK-HepC cohort was 2.2- and 3.4-fold higher than AN and non-AN adults, respectively, and remained stable over time in all populations. The LRD death rate among the AK-HepC cohort was 18- and 11-fold higher than the non-AN and AN, respectively. The liver cancer rate among the AK-HepC cohort was 26-fold higher compared to the Alaska statewide population. The AK-HepC cohort had elevated rates of death associated with nonhepatic diseases with circulatory disease having the highest rate in all populations. Among liver cancer deaths in the AK-HepC cohort, 32% had HCV listed as a contributing cause of death on the death certificate. Conclusions. Death rates in the AK-HepC cohort remained stable since 1995 and higher compared to the general population. People with HCV infection had an elevated risk for all-cause, liver-related, and nonhepatic causes of death. Hepatitis C infection may be underrepresented as a cause of mortality in the United States.</abstract><cop>Oakville</cop><pub>Hindawi</pub><pmid>35178364</pmid><doi>10.1155/2022/2573545</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6439-9714</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2291-2789 |
ispartof | Canadian Journal of Gastroenterology and Hepatology, 2022, Vol.2022, p.1-8 |
issn | 2291-2789 2291-2797 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8847038 |
source | PubMed (Medline); Publicly Available Content Database; Wiley Open Access |
subjects | Adults Age Alcohol Baby boomers Diabetes Hepatitis C Infections Liver cancer Liver diseases Mortality Population |
title | Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A31%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mortality%20among%20Alaska%20Native%20Adults%20with%20Confirmed%20Hepatitis%20C%20Virus%20Infection%20Compared%20with%20the%20General%20Population%20in%20Alaska,%201995%E2%80%932016&rft.jtitle=Canadian%20Journal%20of%20Gastroenterology%20and%20Hepatology&rft.au=Bressler,%20Sara%20S.&rft.date=2022&rft.volume=2022&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=2291-2789&rft.eissn=2291-2797&rft_id=info:doi/10.1155/2022/2573545&rft_dat=%3Cproquest_doaj_%3E2630681280%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-c1c7ad6bea3345936337a1669b76a81d038376cec590d2e2924739fc7d97de003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2630681280&rft_id=info:pmid/35178364&rfr_iscdi=true |